Cobalequin is an orally administered form of B12 that may eliminate or reduce the need for B12 injections
It is a randomized, double-blind, matched-pair, placebo-controlled clinical trial
Rehman T, Shabbir MA, Inam-Ur-Raheem M, Manzoor MF, Ahmad N, Liu ZW, et al
[4] A separate 2024 randomized double-blind trial in people with HIV taking modern integrase-inhibitor regimens found that tesamorelin 2 mg daily significantly reduced both visceral and hepatic fat versus placebo, again without worsening glycemic control in that analysis
HPLC High-Performance Liquid Chromatography confirms peptide purity 98%
Profiles of the Common GLP-1 Receptor Agonists Note: All may cause significant/severe GI symptoms including nausea, vomiting, retching, gastroparesis, abdominal bloating, and pain